Shares of DraftKings (NASDAQ: DKNG) closed slightly lower today, but analysts are still optimistic about the stock's potential in the second half of 2024....
The pharmaceutical industry is facing a significant challenge as several blockbuster drugs are set to lose their patent protection by the end of the...